Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESQU-BLOCK Trial
NCT03745794Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2019
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 2, randomised trial in postoperative pain (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Number of Participants Discharged Opioid-Free at 90 days. Started Feb 2019; status: completed.
02
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03745794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03745794.